Di Xie

Di Xie

Auto-generated profile, based on publicly available information

Di Xie

Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06510

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
DXDi Xie
Di Xie
FCfan chen
fan chen
YZYuanyuan Zhang
Yuanyuan Zhang
BSBei Shi
Bei Shi
JSJiahui Song
Jiahui Song
YHYingqun Huang
Yingqun Huang
Significance: A clear mechanistic understanding of metformin’s antidiabetic effects is lacking. This is because suprapharmacological concentrations of metformin have been used in most studies. Using mouse models and human primary hepatocytes, we show that metformin, at clinically relevant doses, suppresses hepatic glucose production by activating a conserved regulatory pathway encompassing let-7, TET3, and a fetal isoform of hepatocyte nuclear factor 4 alpha (HNF4α). We demonstrate that metformin no longer has potent antidiabetic actions in a liver-specific let-7 loss-of-function mouse model and that hepatic delivery of let-7 ameliorates hyperglycemia and improves glucose homeostasis. Our results thus reveal an important role of the hepatic let-7/TET3/HNF4α axis in mediating the therapeutic effects of metformin and suggest that targeting this axis may be a potential therapeutic for diabetes.

16 September 2026 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
FMFei Meng
Fei Meng
YYYuan Yao
Yuan Yao
ZGZheng Gao
Zheng Gao
XFXiaosheng Fan
Xiaosheng Fan
GLGang Li
Gang Li
YZYinghong Zhu
Yinghong Zhu